Mural Oncology
MURA
MURA was delisted on the 4th of December, 2025.
76 hedge funds and large institutions have $30.5M invested in Mural Oncology in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 9 closing their positions.
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
3% more funds holding
Funds holding: 74 → 76 (+2)
2% more capital invested
Capital invested by funds: $29.8M → $30.5M (+$650K)
0.45% less ownership
Funds ownership: 55.88% → 55.44% (-0.45%)
26% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 23
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $111K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$311K |
| 2 |
Goldman Sachs
New York
|
+$231K |
| 3 |
Morgan Stanley
New York
|
+$180K |
| 4 |
VF
Virtu Financial
New York
|
+$141K |
| 5 |
Renaissance Technologies
New York
|
+$125K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFA
Alta Fundamental Advisers
New York
|
-$2.25M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.05M |
| 3 |
CC
Centiva Capital
New York
|
-$638K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$469K |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$366K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Point72 Asset Management
Stamford,
Connecticut
| – | -$340K | -108,715 | Closed |
|
77
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$35.9K | -11,465 | Closed |
|
|
NA
78
Nordwand Advisors
Radnor,
Pennsylvania
| – | -$3.13K | -1,000 | Closed |
|
79
Credit Agricole
Montrouge Cedex,
France
| – | -$470 | -150 | Closed |
|
80
Group One Trading
Chicago,
Illinois
| – | -$384 | -109 | Closed |
|
|
PPC
81
Park Place Capital
Homewood,
Alabama
| – | -$194 | -62 | Closed |
|
|
BTI
82
Blue Trust Inc
Alpharetta,
Georgia
| – | -$19 | -6 | Closed |
|
83
Bessemer Group
Woodbridge,
New Jersey
| – | +$32 | +9 | New |
|
MURA Hedge Fund Activity: Q4 2024 in Review
76 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q4 2024, worth a combined $30.5M — up 2.2% from $29.8M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new MURA positions and 9 closed out — a net gain of 2 holders — while 17 added to existing stakes and 23 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $311K. The largest seller was Alta Fundamental Advisers, exiting entirely with an estimated $2.25M sold.
- 76 institutional investors held Mural Oncology (MURA) as of Q4 2024, up from 74 in Q3 2024.
- Funds reported $30.5M of Mural Oncology stock for Q4 2024, up 2.2% quarter-over-quarter.
- 11 funds opened new Mural Oncology positions in Q4 2024 and 9 closed out, a net change of +2 holders.
- The largest Mural Oncology buyer in Q4 2024 was Citadel Advisors, an estimated $311K added.
- The largest Mural Oncology seller in Q4 2024 was Alta Fundamental Advisers, an estimated $2.25M sold.
Based on aggregated 13F filings for Q4 2024.